AI-generated analysis. Always verify with the original filing.
Context Therapeutics Inc. disclosed amendments to its Amended and Restated Certificate of Incorporation via a Certificate of Correction (Exhibit 3.1), dismissal with prejudice of a prior action as to the plaintiff on March 11, 2026 pursuant to a Stipulated Judgment, and the court's retained jurisdiction. These updates relate to Item 5.03 governance changes and Item 8.01 other events.
Event Type
Disclosure
Mandatory
Variant
8-K
. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. As previously disclosed, on February 24, 2026, a stipulation and proposed consent ju
. Other Events. On March 11, 2026, pursuant to the Stipulated Judgment, the Action was dismissed with prejudice as to plaintiff; however, the Court retains juri
. Financial Statements and Exhibits. ( d) Exhibits Exhibit No. Description 3.1 Certificate of Correction to the Amended and Restated Certificate of Incorporatio